Rimidi key facts
- Developer of cloud-based software designed to enable chronic disease management.
- Rimidi’s last known valuation is $32.0M (Jul 2018).
- It has raised $22.6M across 8 recorded rounds; the latest was Seed Round ($450K) in Aug 2025.
- Notable investors include Impact Assets, Springboard Enterprises, Village Capital, VentureWell, Album VC — 22 tracked in total.
- Rimidi has filed 7 Form Ds with the SEC since 2018, most recently Aug 2025 ($450K sold to 1 investors).
- Status: Acquired/Merged (Operating Subsidiary).
Who backs Rimidi
22+- ·The complete investor list: 22 names
- ·Watch Rimidi: the Monday email on marks, rounds and moves
Rimidi funding rounds
8 roundsRimidi valuation
Rimidi's last known valuation is $32 million, from Jul 2018. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
How much has Rimidi raised?
Rimidi has raised $22.6 million across 8 recorded rounds since 2018. The largest was an $800,000 seed round in May 2025; the most recent was a $450,000 seed round in Aug 2025.
Rimidi has filed 7 Form Ds with the SEC since 2018, most recently in Aug 2025 ($450,000 sold to 1 investor).
Rimidi investors
22 investors are on record for Rimidi, including Impact Assets, Springboard Enterprises, Village Capital and VentureWell. The seed round in Aug 2025 drew 1 investor.
Comparable companies
Comparable enterprise systems (healthcare) names by valuation on PrivateMarketView: Plenful ($68 million), ThoroughCare ($53 million) and Arintra ($44.3 million).
About Rimidi
Developer of cloud-based software designed to enable chronic disease management. The company's platform works within the EHR and combines patient-generated health data from connected devices with clinical data to drive patient-specific insights and provides a risk stratification view, enabling clinicians to remotely monitor their patient's progress and virtually send encouragement or treatment adjustments when necessary.
- Industry
- Enterprise Systems (Healthcare)
- Sector
- Healthcare
- HQ
- Atlanta, GA, United States
- Founded
- 2012
- Employees
- 32
- Website
- rimidi.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Rimidi’s last known valuation, Jul 2018. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.